造血
生物
突变体
干细胞
TXNIP公司
突变
祖细胞
体细胞
细胞生物学
遗传学
癌症研究
基因
硫氧还蛋白
作者
Christine Zhang,Elizabeth L. Ostrander,Ostap Kukhar,Cates Mallaney,Jiameng Sun,Emily Haussler,Hamza Celik,Won Kyun Koh,Katherine Y. King,Paul Gontarz,Grant A. Challen
出处
期刊:Blood cancer discovery
[American Association for Cancer Research]
日期:2022-04-08
卷期号:3 (3): 220-239
被引量:17
标识
DOI:10.1158/2643-3230.bcd-21-0132
摘要
Clonal hematopoiesis (CH) refers to the age-related expansion of specific clones in the blood system, and manifests from somatic mutations acquired in hematopoietic stem cells (HSCs). Most CH variants occur in the gene DNMT3A, but while DNMT3A-mutant CH becomes almost ubiquitous in aging humans, a unifying molecular mechanism to illuminate how DNMT3A-mutant HSCs outcompete their counterparts is lacking. Here, we used interferon gamma (IFNγ) as a model to study the mechanisms by which Dnmt3a mutations increase HSC fitness under hematopoietic stress. We found Dnmt3a-mutant HSCs resist IFNγ-mediated depletion, and IFNγ-signaling is required for clonal expansion of Dnmt3a-mutant HSCs in vivo. Mechanistically, DNA hypomethylation-associated overexpression of Txnip in Dnmt3a-mutant HSCs leads to p53 stabilization and upregulation of p21. This preserves the functional potential of Dnmt3a-mutant HSCs through increased quiescence and resistance to IFNγ-induced apoptosis. These data identify a previously undescribed mechanism to explain increased fitness of DNMT3A-mutant clones under hematopoietic stress.DNMT3A mutations are common variants in clonal hematopoiesis, and recurrent events in blood cancers. Yet the mechanisms by which these mutations provide hematopoietic stem cells a competitive advantage as a precursor to malignant transformation remain unclear. Here, we use inflammatory stress to uncover molecular mechanisms leading to this fitness advantage.See related commentary by De Dominici and DeGregori, p. 178. This article is highlighted in the In This Issue feature, p. 171.
科研通智能强力驱动
Strongly Powered by AbleSci AI